新兴技术用于识别针对帕金森病的传统中医衍生分子
Yanzhuo Jin1, Yurun Yang1, Yiran Sun1
1Wisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
ACS chemical neuroscience
|June 12, 2025
概括
中国传统医学为帕金森病治疗提供天然化合物,准α-synuclein聚合和神经炎症. 像质谱仪这样的先进技术有助于发现新的治疗分子.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 传统医学的传统医学.
背景情况:
- 帕金森病涉及α-synuclein聚合和多巴胺能神经元损失.
- 现有的神经保护分子在特异性和效率方面面临挑战.
- 传统中国医学 (TCM) 呈现了具有治疗潜力的多种天然化合物.
研究的目的:
- 为了比较分析TCM衍生分子用于帕金森病 (PD) 治疗.
- 为突出在PD中药物发现的先进分析技术.
- 将传统知识与现代科学相结合,为新的PD疗法提供新的治疗方法.
主要方法:
- 关于TCM化合物及其在PD中的机制的文献综述.
- 对tanshinones,paeoniflorin和ginsenosides等分子的分析.
- 重点是质谱和磁珠用于化合物识别和选.
主要成果:
- TCM化合物显示出抑制细胞亡和神经炎症的潜力.
- 这些分子可以调节α-synuclein聚合和清除.
- 先进的技术加速了生物活性化合物的识别和表征.
结论:
- 传统中医药为帕金森病治疗提供了有前途的天然药物.
- 将TCM与现代分析方法相结合,提高了药物发现效率.
- 进一步的研究可以开发新的,有效的帕金森病治疗方法.
关键词:
帕金森病是帕金森氏症的一种疾病.磁性珠子 磁性珠子质谱测量质谱测量质谱测量质量测量质谱测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量传统的中医药是传统的中医药.α-synuclein 是一种同核蛋白.更多相关视频
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
238
相关概念视频
01:24Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
01:15Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495